The phase III OPTIMA trial, presented at this year's American Society of Clinical Oncology (ASCO) annual meeting, showed that some patients with high-risk, early-stage, estrogen receptor (ER)-positive ...
Alcohol is linked to 20 health conditions, from 10 cancer types to liver disease, dementia, and heart rhythm disorders. The ...
Studies do not confirm the benefits of wearing a bra. Is it really necessary? Professionals respond about its use: comfort ...
Many people take dietary supplements hoping to improve their health, boost their energy, and slow down the aging process. One ...
The gene, known as EXO1, normally helps maintain genomic stability by repairing damaged DNA. But the researchers found that ...
Experts said choline deficiency can cause the liver to store excess fat and raise fatty liver risk. They also flagged its ...
Nancy E. Davidson, MD, executive vice president and chief academic officer at Fred Hutch Cancer Center, is the recipient of ...
Qurient announced the first patient dosed in a Phase 2 study of mocaciclib (Q901) for CDK4/6 inhibitor-resistant HR+ breast ...
Omitting completion axillary lymph node dissection does not increase risk for death for patients with clinically node-negative breast cancer, but it does significantly improve arm distress.Data from ...
The largest randomized trial of its kind to date found noninferior survival and better arm morbidity among patients with breast cancer who did not undergo completion axillary lymph node dissection.
Historically, a positive SLNB necessitated completion ALND to ensure removal of additional cancer that lymph nodes might harbor, said de Boniface. Axillary surgery may lead to multiple arm-related ...
Five-year OS was 94.4% with ALND omission vs 93.4% with completion ALND (HR 0.89), confirming non-inferiority; breast cancer–specific survival was similarly high in both arms. Inclusion of mastectomy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results